EQS-PVR: BB BIOTECH AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Disclosure of Shareholdings Submitted, 27/08/2025

Notification ID: e47fac60-e851-45fe-a790-702783d0f346

 

Disclosure notification concerning a single investor Name of listed company BB Biotech AG  

PART 1: PERSON SUBJECT TO REPORTING OBLIGATION

Last name, first name, place of residence or company name and head office of the beneficial owner (art. 120 para. 1 FMIA) and/ or of the person who has the discretionary power to exercise the voting rights (art. 120 para. 3 FMIA):

Company: Saba Capital Management, L.P.

City: New York

Country: United States of America (the)

 

PART 2: IN CASE OF INDIRECT PARTICIPATION

Last name, first name, place of residence or company name and head office of the person/s directly involved

 

PART 3: DATE AND REASON FOR THE REPORTING OBLIGATION

Date of the act that creates the obligation to notify: 26.08.2025

Facts and circumstances triggering the obligation to notify (art. 22 para. 1 b FMIO-FINMA):

X Acquisition

Sale

Creation of a group

Change in group composition Termination of a group

Discretionary exercise of voting rights

Securities lending and comparable transactions

Exercise, non-exercise or expiration of derivative holdings

Granting (writing) of derivative holdings

Capital increase

Capital reduction

Ipso jure transfer or transfer due to a decision by a court or public authority

Change in the information subject to the obligation to notify

Other  Total of voting rights below 3%

If the participation falls below the threshold of 3% (purchase positions and sale positions), no indication in Part 4 or Part 5 is required.

_   Total of voting rights <3%

PART 4: PURCHASE POSITIONS PURSUANT TO ART. 14 PARA. 1 A FMIO-FINMA

Total of all purchase positions:

Total of all equity securities or equity related securities (item 1), number of voting rights that can be exercised at one’s own discretion (item 3) and derivative holdings (item 4)

Numberofvotingrights	Percentage
S1 = [1.1] + [3.1] + [4.1]	S2 = [1.2] + [3.2] + [4.2]
2,772,044	5.004%

 

Basis of calculation (art. 14 para. 2 FMIO-FINMA): total number of voting rights pursuant to the entry in the commercial register (see Central Business Names Index) or Publication according to art. 115 para. 3 FMIO:

 55,400,000   

1. Equity securities or equity related securities

Shares	Number	Votingrights1
		Number	Percentage2
Registeredshare	1,677,359	1,677,359	3.028%
Total		[1.1] 1,677,359	[1.2] 3.028%

1. Whether exercisable or not
2. Calculated on the basis of the total number of voting rights pursuant to the entry in the commercial register (art. 14 para. 2 FMIO-FINMA)

 

2. Securities lending and comparable transactions in equity securities

Of the equity securities mentioned in item 1 above, the following part is held due to securities lending and comparable transactions (art. 17 FMIO-FINMA):

 

Shares

Number

Proportionof votingrights

Natureofthe legal transaction

Agreeddateofreturntransfer or,ifthereisarighttochoose, whether this applies to the contracting party subject tothe obligation to notify or to thecounterparty

 

3. Voting rights that can be exercised at one's own discretion

The following voting rights were delegated by a third party and can be exercised at one's own discretion.

 

Votingrights

Is the person who has full discretionary powers to exercise voting rights directly or indirectly controlled?

Yes  No

4. Derivative holdings

Conversion and share purchase rights (such as call-options according to art. 15 para. 2 a FMIO-FINMA), granted (written) share sale rights and other derivative holdings:

 

Typeofrights	Numberofrights	Numberofvotingrightsconferred		SecurityIDnumber(ISIN)ifavailableorbasicterms
		Number	Percentage2	Identity of issuer, subscription ratio, exercise price, exercise period, exercise type
CFD	1,094,685	1,094,685	1.976%	CH0038389992
		[4.1]	[4.2]
Total		1,094,685	1.976%

2 Calculated on the basis of the total number of voting rights pursuant to the entry in the commercial register (art. 14 para. 2 FMIO-FINMA)

 

5. Securities lending and comparable transactions in derivative holdings

Of the derivative holdings mentioned in item 4 above, the following part is held due to securities lending and comparable transactions (art. 17 FMIO-FINMA):

 

Natureofthelegaltransaction

Numberofrights

Numberof reportedvoting rights

Proportionofvotingrights

Agreeddateofreturntransfer or,ifthereisarighttochoose, whether this applies to the contracting party subject tothe obligation to notify or to thecounterparty

PART 5: SALE POSITIONS PURSUANT TO ART. 14 PARA. 1 B FMIO-FINMA

Total of all sale positions:  Basis of calculation (art. 14 para. 2 FMIO-FINMA): total number of voting rights pursuant to the entry in the commercial register (see Central Business Names Index) or Publication according to art. 115 para. 3 FMIO:

 55,400,000 

 

Derivative holdings

Share sale rights (such as put-options according to art. 15 para. 2 a FMIO-FINMA), granted (written) conversion and share purchase rights and other derivative holdings:

 

Typeofrights	Numberofrights	Numberofvotingrightsconferred		SecurityIDnumber(ISIN)ifavailableorbasicterms
		Number	Percentage2	Identity of issuer, subscription ratio, exercise price, exercise period, exercise type

Total

2 Calculated on the basis of the total number of voting rights pursuant to the entry in the commercial register (art. 14 para. 2 FMIO-FINMA)